Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Insurer Anthem warns of higher non-COVID-19 costs in coming quarters

04/21/2021 | 11:01am EDT
FILE PHOTO: The office building of health insurer Anthem is seen in Newbury Park, California

(Reuters) -Anthem Inc on Wednesday warned of higher medical costs in the coming quarters due to a sooner-than-anticipated rebound in demand for non-COVID-19 healthcare services as more Americans get vaccinated.

For much of last year when the pandemic was at its peak, health insurers benefited from lower patient use of elective, non-COVID healthcare services.

"Given a faster rollout of the vaccine, we expect non-COVID utilization to rebound sooner, and we now expect to absorb higher COVID vaccination administration costs during the second quarter," Anthem Chief Financial Officer John Gallina said.

Shares of the company were down about 0.5% at $380.30.

"The expected return of care utilization is somewhat optimistic. We continue to see variable inoculation rates for COVID-19 across specific markets, as well as hesitancy from consumers to return to in-person care," Forrester analyst Arielle Trzcinski said.

Anthem's comments were made during a post-earnings conference call after the company reported quarterly profit that beat estimates and raised its full-year profit outlook.

The raise follows a similar move by larger rival UnitedHealth, which said last week it saw a decline in COVID-19 related expenses during February and March as U.S. vaccination efforts helped ease case burden.

For 2021, Anthem expects adjusted net profit of more than $25.10 per share, up from its previous forecast of over $24.50 per share.

Gallina said the company's forecast assumes a negative impact from the potential for a prolonged fourth wave of COVID-19 and pent-up demand for healthcare services that were delayed by patients throughout the pandemic.

Even though Anthem's outlook assumes COVID-19 related costs of about $600 million, it stuck to its long-term annual target of 12% to 15% growth in adjusted profit.

Excluding items, Anthem earned $7.01 per share in the quarter ended March 31, compared with analysts' average estimate of $6.51.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)

By Manojna Maddipatla and Mrinalika Roy


ę Reuters 2021
Latest news "Economy & Forex"
01:39aSingapore's DBS bets on post-pandemic recovery, profit up on lower credit costs
RE
01:38aDollar firm as Fed members map road to rate hike
RE
01:31aDollar firm as Fed members map road to rate hike
RE
01:28aLufthansa narrows quarterly loss, returns to positive cash flow
RE
01:18aIndian shares slip after strong rally; Vodafone Idea slumps 24%
RE
01:15aCharlie Watts drops out of Rolling Stones' upcoming U.S. tour
RE
01:03aANOTHER WEAK MONTH FOR CRUDE IMPORTS IN ASIA UNDERCUTS OIL BULLS : Russell
RE
01:01aIndonesia exits recession with 7% GDP growth in Q2, but virus clouds recovery
RE
01:00aChina shares muted; investors worry about Beijing's crackdown
RE
12:55aBoeing 737 MAX departs for key test flight in China
RE
Latest news "Economy & Forex"